Indivior

FDA to reconsider Braeburn’s opioid addiction drug after court ruling
FDA to reconsider Braeburn’s opioid addiction drug after court ruling
Pharmaforum
FDA
opioids
opioid addiction
Braeburn Pharmaceuticals
Indivior
Brixadi
Flag link:
Indivior loses appeal to block generic Suboxone opioid treatments
Indivior loses appeal to block generic Suboxone opioid treatments
Reuters
Indivior
Dr Reddy's
Alvogen
generics
Suboxone
opioids
Flag link:
Billion-dollar settlment gets Reckitt out of federal opioid probes
Billion-dollar settlment gets Reckitt out of federal opioid probes
Biopharma Dive
Reckitt Benckiser
opioids
opioid crisis
opioid addiction
Indivior
Suboxone
Flag link:
Drugmaker Petitions FDA to Revoke Sublocade Orphan Designation
Drugmaker Petitions FDA to Revoke Sublocade Orphan Designation
RAPS.org
Braeburn Pharmaceuticals
citizen petitions
FDA
orphan drug
Sublocade
Indivior
Flag link:
U.S. fraud charges pummel Indivior shares
U.S. fraud charges pummel Indivior shares
BioCentury
Indivior
DOJ
fraud
opioid withdrawal
Suboxone Film
Flag link:
Indivior introduces generic version of Suboxone opioid drug in US
Indivior introduces generic version of Suboxone opioid drug in US
Pharmaceutical Business Review
Indivior
Sandoz
generics
opioids
Suboxone Film
Flag link:
US court rejects Indivior’s appeal on Suboxone generic version
US court rejects Indivior’s appeal on Suboxone generic version
Pharmaceutical Business Review
Indivior
generics
Suboxone Film
Dr Reddy's
opioid addiction
Flag link:
Indivior to Sell Rights in China for $122 Million
Indivior to Sell Rights in China for $122 Million
CP Wire
China
Indivior
Pukang
Flag link:
Indivior to Sell Rights in China for $122 Million
Indivior
Flag link:
Indivior faces huge sales loss as Suboxone court loss puts generics on tap next week
Indivior faces huge sales loss as Suboxone court loss puts generics on tap next week
Fierce Pharma
Indivior
Suboxone Film
generics
Flag link:
Indivior temporarily stops rival Alvogen's generic launch
Indivior temporarily stops rival Alvogen's generic launch
Reuters
Indivior
Alvogen
generics
opioid addiction
Suboxone
Flag link:
U.S. court allows generic version of Indivior opioid abuse drug
U.S. court allows generic version of Indivior opioid abuse drug
Reuters
Dr Reddy's
Indivior
Suboxone Film
Flag link:
Teva holding off launch of opioid addiction drug
Teva holding off launch of opioid addiction drug
Pharmaforum
Teva Pharmaceutical
opioids
opioid addiction
generics
Dr Reddy's
Suboxone
Indivior
Flag link:
As it fights looming competition on Suboxone, Indivior gets FDA OK on new schizophrenia drug
As it fights looming competition on Suboxone, Indivior gets FDA OK on new schizophrenia drug
Endpoints
Indivior
FDA
Perseris
schizophrenia
Suboxone
Flag link:
Indivior's shares soar 33 percent after U.S. court blocks sale of rival generic
Indivior's shares soar 33 percent after U.S. court blocks sale of rival generic
Reuters
Indivior
opioid addiction
generics
Suboxone Film
Dr Reddy's
Flag link:
Indivior shares dive after Dr Reddy's gets FDA approval for generic
Indivior shares dive after Dr Reddy's gets FDA approval for generic
Reuters
Indivior
FDA
generics
Suboxone Film
opioids
opioid addiction
Flag link:
Indivior Files Complaints Asserting New Suboxone Film Patent Against ANDA-Filers
Suboxone Film
opioid addiction
Indivior
Flag link:
In a blow to its biggest revenue driver, Indivior loses patent battle with generics maker Alvogen
In a blow to its biggest revenue driver, Indivior loses patent battle with generics maker Alvogen
Endpoints
Indivior
patents
Suboxone
Alvogen
generics
Flag link:
12 blockbusters: The surging list of $1B-plus drugs rolling out on the market this year might surprise you
12 blockbusters: The surging list of $1B-plus drugs rolling out on the market this year might surprise you
Endpoints
drug launches
Hemlibra
Roche
Biktarvy
Gilead Sciences
Ozempic
Novo Nordisk
Erleada
JNJ
Shingrix
GSK
Patisiran
Alnylam
Sanofi
Epidiolex
GW Pharma
Aimovig
Amgen
Novartis
lanadelumab
Shire
Elagolix
AbbVie
Steglatro
Pfizer
Merck
Sublocade
Indivior
Flag link:
FDA panel votes yes on Indivior’s opioid addiction drug
FDA panel votes yes on Indivior’s opioid addiction drug
Endpoints
FDA
advisory panels
Indivior
opioid addiction
RBP-6000
buprenorphine
Flag link:

Pages